The Online Investor

Slideshow Secondary Stock Offerings

By The Online Investor Staff, updated Sat., Sep. 19, 8:42 AM

Slide #10. 89bio, Inc. Secondary Offering

Company: 89bio, Inc. (NASDAQ:ETNB)
Date announced: 9/14/2020
Shares Offered: 3,300,000
Date of Pricing: 9/16/2020
Price Per Share: $28.00
Secondary Offering Details: 89bio, Inc. (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases, today announced that it has commenced an underwritten public offering of 3,000,000 shares of its common stock, which includes 2,700,000 shares of the common stock offered by the company and 300,000 shares of the common stock offered by certain of the company's stockholders. In addition, the company and a selling stockholder is expected to grant the underwriters of the offering an option for a period of 30 days to purchase up to an additional 175,000 shares of common stock and 275,000 shares of common stock, respectively, at the public offering price, less the underwriting discounts and commissions. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering. -updated 9/16- 89bio, Inc. (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases, today announced the pricing of an upsized underwritten public offering of 3,300,000 shares of its common stock at a public offering price of $28.00 per share. 3,025,000 shares are being offered by 89bio, and 275,000 shares are being offered by a selling stockholder. The gross proceeds of the offering to 89bio, before deducting the underwriting discount and other offering expenses payable by 89bio, are expected to be approximately $84.7 million. In addition, 89bio has granted the underwriters a 30-day option to purchase up to an additional 495,000 shares of common stock, at the public offering price, less the underwriting discounts and commissions. 89bio will not receive any proceeds from the sale of shares of the company's common stock by the selling stockholder. The offering is expected to close on September 21, 2020, subject to the satisfaction of customary closing conditions.

89Bio operates as a clinical-stage biopharmaceutical company. Co. focuses on developing therapies and drugs for treatments of patients living with nonalcoholic steatohepatitis (NASH) and other liver and metabolic disorders. Co. serves customers in the United States and Israel.
Open the ETNB Page at The Online Investor »

Company Name: 
89bio Inc
Website: 
www.89bio.com
Sector: 
Drugs & Pharmaceuticals
Number of ETFs Holding ETNB: 
9
Total Market Value Held by ETFs: 
$8.10M
Total Market Capitalization: 
$492.00M
% of Market Cap. Held by ETFs: 
1.65%
 

Open the ETNB Page at The Online Investor (in a new window) »

Quotes delayed 20 minutes



Strong Buy (3.83 out of 4)
77th percentile
(ranked higher than approx. 77% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite

Secondary Stock Offerings Page | www.TheOnlineInvestor.com

Copyright © 1998 - 2020, All Rights Reserved
Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.